PROGRESS OF PD-1/PD-L1 INHIBITORS IN NON-SMALL CELL LUNG CANCER

Progress of PD-1/PD-L1 Inhibitors in Non-small Cell Lung Cancer

Pembrolizumab, an inhibitor target programmed death 1 (PD-1), Huge was approved into the first line therapy in advanced non-small cell lung cancer (NSCLC).It was a milestone that immune checkpoints drugs have played an important role in the treatment system of NSCLC.The results of clinical trials revealed the superiority of PD-1/programmed death li

read more

The teachings of John Paul II and the paradoxes of the right to life in the International Human Rights discourse

The right to life has a unique and outstanding importance in the International Human Rights Law.However, at the same time, this right suffers from Gift Card new threats and contradictions.In this paper, I will address these paradoxes, concerning the moment, in which the legal protection of the human being begins; the tendency to accommodate the beg

read more